Avivagen Stock Analysis
| VIVXF Stock | USD 0.0001 0.00 0.00% |
Avivagen is overvalued with Real Value of 7.6E-5 and Hype Value of 6.0E-5. The main objective of Avivagen pink sheet analysis is to determine its intrinsic value, which is an estimate of what Avivagen is worth, separate from its market price. There are two main types of Avivagen's stock analysis: fundamental analysis and technical analysis.
The Avivagen pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Avivagen's ongoing operational relationships across important fundamental and technical indicators.
Avivagen |
Avivagen Pink Sheet Analysis Notes
The company recorded a loss per share of 0.08. Avivagen last dividend was issued on the 25th of May 2017. The entity had 1:10 split on the 25th of May 2017. Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada. Avivagen is traded on OTC Exchange in the United States.The quote for Avivagen is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call G Anthony at 613 702 2908 or visit https://www.avivagen.com.Avivagen Investment Alerts
| Avivagen generated a negative expected return over the last 90 days | |
| Avivagen has high historical volatility and very poor performance | |
| Avivagen has some characteristics of a very speculative penny stock | |
| Avivagen has a very high chance of going through financial distress in the upcoming years | |
| Avivagen has accumulated 1.4 M in total debt. Avivagen has a current ratio of 0.79, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Avivagen until it has trouble settling it off, either with new capital or with free cash flow. So, Avivagen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Avivagen sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Avivagen to invest in growth at high rates of return. When we think about Avivagen's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 1.3 M. Net Loss for the year was (6.39 M) with profit before overhead, payroll, taxes, and interest of 534.34 K. | |
| Avivagen has accumulated about 494.81 K in cash with (4.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Avivagen Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Avivagen's market, we take the total number of its shares issued and multiply it by Avivagen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 30th of November, Avivagen shows the Standard Deviation of 11.97, mean deviation of 2.9, and Risk Adjusted Performance of (0.08). In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Avivagen, as well as the relationship between them. Please confirm Avivagen variance and kurtosis to decide if Avivagen is priced correctly, providing market reflects its regular price of 1.0E-4 per share. As Avivagen appears to be a penny stock we also recommend to validate its information ratio numbers.Avivagen Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Avivagen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Avivagen. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Avivagen Predictive Daily Indicators
Avivagen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Avivagen pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Avivagen Forecast Models
Avivagen's time-series forecasting models are one of many Avivagen's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Avivagen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Avivagen Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Avivagen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Avivagen shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Avivagen. By using and applying Avivagen Pink Sheet analysis, traders can create a robust methodology for identifying Avivagen entry and exit points for their positions.
Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada. Avivagen is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Avivagen to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Complementary Tools for Avivagen Pink Sheet analysis
When running Avivagen's price analysis, check to measure Avivagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avivagen is operating at the current time. Most of Avivagen's value examination focuses on studying past and present price action to predict the probability of Avivagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avivagen's price. Additionally, you may evaluate how the addition of Avivagen to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |